LifeStance Health Group LFST Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 3%+1.3pp | 1.7%+1.3pp | 0.4%+0.5pp | -0.1%+1.0pp | -1.1%+1.5pp | |
| Net margin | 1.6%+0.9pp | 0.7%+1.3pp | -0.7%+0.1pp | -0.7%+1.5pp | -2.3%+1.8pp | |
| Returns | ||||||
| Return on equity | 1.6%+0.9pp | 0.7%+1.3pp | -0.6%0.0pp | -0.7%+1.4pp | -2%+1.5pp | |
| Return on invested capital | 1.7%+0.7pp | 1.1%+0.7pp | 0.3%+0.4pp | -0.1%+0.7pp | -0.8%+1.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.2× | 1.7×+0.1× | 1.6×+0.1× | 1.5×0.0× | 1.5×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 2.8×0.0× | 2.9×-1.5× | 4.3×-0.7× | 5.1×— | —— | |
| Per Share | ||||||
| Book value per share | $3.74-3.8% | $3.89+1.3% | $3.84+0.7% | $3.81+2.2% | $3.73-2.2% | |
| Valuation | ||||||
| Market capitalization | $2.44B-11.0% | $2.74B+28.0% | $2.14B+8.3% | $1.98B-22.9% | $2.56B-9.2% | |
| Price / sales | 1.6×-0.3× | 1.9×+0.4× | 1.6×+0.1× | 1.5×-0.5× | 2×-0.3× | |
| Price / book | 1.7×-0.2× | 1.8×+0.4× | 1.4×+0.1× | 1.3×-0.4× | 1.8×-0.2× | |
| EV / EBITDA | 27.4×-10.1× | 37.6×-1.2× | 38.8×-1.4× | 40.2×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do LifeStance Health Group's ratios come from?
- Every ratio is computed from LifeStance Health Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.